JD Health International Inc. disclosed that on 26 May 2026 it repurchased 2.54 million ordinary shares on the Hong Kong Stock Exchange at prices ranging from HKD 38.44 to HKD 40.02. The transaction cost HKD 100.63 million.

Including this latest tranche, the company has bought back 11.61 million shares between 15 May and 26 May 2026, equivalent to 0.36% of the total shares outstanding as at the date of the 20 June 2025 share-repurchase mandate. All repurchased shares are earmarked for cancellation.

JD Health’s issued share capital stood at 3.21 billion shares both before and after the 26 May transaction; the repurchased shares await formal cancellation. Under the existing mandate, the company was originally authorised to repurchase up to 320.01 million shares, leaving a balance of 308.40 million shares available.

In line with Hong Kong listing rules, JD Health is subject to a moratorium on issuing new shares until 25 June 2026.